BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• BioMidwest

  AbbVie to Keep Pharma CMO Biz After Spinoff From Abbott Laboratories

  June 6, 2012

   · 

  1 min read
• Drug Development

  CalAsia Pharmaceuticals, Inc. , a Structure-Based Drug-Discovery Company; Seeks Corporate Partners to Complete the Pre-Clinical Development of Its Proprietary HSP90 Inhibitor Series

  June 6, 2012

   · 

  2 min read
• Biotech Bay

  ChemoCentryx, Inc. to Present at the 2012 Wells Fargo Securities Healthcare Conference

  June 6, 2012

   · 

  1 min read
• Business

  Australian National University to Grant BioDiem Ltd. Exclusive License for Novel Technology to Target Infectious Diseases

  June 6, 2012

   · 

  4 min read
• Drug Development

  NovaBay Pharmaceuticals, Inc. Announces Successful End-of-Phase 2a FDA Meeting for Dermatology Program

  June 6, 2012

   · 

  1 min read
• Trinity Biotech Announces Details of Its Dividend and Share Buyback Program

  June 6, 2012

   · 

  1 min read
• Pharm Country

  ECRI Institute PSO’s Deep Dive Review of Medication Events Leads to New Recommendations for Prevention

  June 6, 2012

   · 

  3 min read
• Pharm Country

  Synergy Pharmaceuticals Announces Partial Exercise of Over-Allotment Option by Aegis Capital Corp.

  June 6, 2012

   · 

  1 min read
• President of Israeli Weizmann Institute of Science Meets With Representatives of the Health Axis Europe Alliance in Heidelberg

  June 6, 2012

   · 

  4 min read
• Drug Development

  Celgene International Sárl Advances ABRAXANE® (nab-paclitaxel) Development in Difficult-to-Treat Cancers

  June 6, 2012

   · 

  1 min read